ImmunoGen

www.immunogen.com

ImmunoGen Reviews

7 Reviews
3.6
7 Reviews
Rating Trends

Recommend to a friend
Approve of CEO
ImmunoGen President, CEO, and Director Dan Junius
Dan Junius
5 Ratings
  •  

    Great place to work!

    • Comp & Benefits
    • Work/Life Balance
    • Senior Management
    • Culture & Values
    • Career Opportunities
    Current Employee - Anonymous Employee
    Current Employee - Anonymous Employee

    I have been working at ImmunoGen full-time (more than 3 years)

    Pros

    Smart people. Great technology and internal pipeline with several partnered molecules as well. Royalty stream coming in now. Great benefits. Fun atmosphere.

    Cons

    Waltham location is not as vibrant as Cambridge...but easier commute!

    Advice to ManagementAdvice

    Keep it up!

    Recommends
    Positive Outlook

ImmunoGen Interviews

Interview Experience

Interview Experience

100%
0%
0%

Getting an Interview

Getting an Interview

50%
25%
25%

Interview Difficulty

3.2
Average

Interview Difficulty

Hard

Average

Easy
  1.  

    Clinical Trials Assistant Interview

    Anonymous Interview Candidate in Waltham, MA
    Anonymous Interview Candidate in Waltham, MA
    Application Details

    I applied online. The process took 4 weeksinterviewed at ImmunoGen.

    Interview Details

    The process was quite easy. The interviews were all done in one day, however, there were many people with which I had to meet. Long day, but overall good experience.

    Interview Questions
    • There weren't any really hard questions asked. Mostly were simply "Do you know how to..." or "What would you do if..." questions.   Answer Question
    Negotiation Details
    There wasn't a lot to the negotiation. The initial offer was just under what I was looking for so it made that process pretty easy.
    Accepted Offer
    Positive Experience
    Easy Interview

ImmunoGen Awards & Accolades

Let us know if we're missing any workplace or industry recognition – Add an award

Additional Info

Unlock Profile
Website www.immunogen.com
Headquarters Waltham, MA
Size 150 to 499 Employees
Founded 1981
Type Company - Public (IMGN)
Industry Biotech & Pharmaceuticals
Revenue $50 to $100 million (USD) per year
Competitors Pfizer, Amgen, Seattle Genetics

ImmunoGen is TAP, TAP, TAPping its way toward a cure for cancer. The firm's product candidates are TAPs, or tumor-activated prodrugs, that combine cancer-killing drugs with monoclonal antibodies (single-source proteins) and attach only to tumor cells. Its lead compounds are trastuzumab emtansine, which is being developed with Genentech to treat breast cancer; lorvotuzumab mertansine to treat solid tumors and multiple myelomas; and SAR3419 for non-Hodgkin's lymphoma. Along with good ol' R&D, a large part of ImmunoGen's business is derived from licensing its TAP technology... More

Work at ImmunoGen? Share Your Experiences

ImmunoGen

 
Click to Rate
or